Bollard Group’s HCA Healthcare HCA Stock Holding History

Bollard Group’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35	Closed	-$11K	–	510
2023 Q2	$11K	Buy	+35	New	+$9.73K	﹤0.01%	291

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bollard Group's HCA Position: Q3 2023 in Review

Bollard Group sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 35 shares — an estimated $11K sold.

Bollard Group first reported a position in HCA in Q2 2023 and held it in 1 quarter. The position peaked at $11K in Q2 2023. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

Bollard Group reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
Bollard Group sold 35 HCA Healthcare shares in Q3 2023, an estimated $11K.
Bollard Group first reported a position in HCA Healthcare in Q2 2023 and held it in 1 quarter.
Bollard Group's HCA Healthcare position peaked at $11K in Q2 2023.
1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.